Climb Bio CLYM SEC Filings

NASDAQ CLYM
$15.52 +0.93 (+6.37%)
As of: Sep 4, 2026 · 3:59 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Climb Bio, Inc. (CLYM) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index